Company
AirNexis Therapeutics, Inc.
Respiratory treatment designed to fit your life.
Also known as AirNexis Therapeutics
- Business model
- B2B
- Headquarters
- Redwood City, California, United States
- Founded
- 2026
- Legal name
- AirNexis Therapeutics, Inc.
- airnexis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
AirNexis is developing AN01, a first of its kind dry powder inhaler for COPD. Its targeted mechanism of action relaxes the airways, improving airflow to the lungs, and cuts down inflammation.
Funding snapshot
- Total raised
- $62MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $200M2026-01-09
Funding rounds
- Series A
- $200M2026-01-09, Company stated
- Round, 2026
- $62M2026-01-09, SEC form D sold, 13 investors
Products
- Other
- AN01
- Web
- AN01
Loading relationship preview